InvestorsHub Logo
icon url

VistaViewer

10/26/07 2:20 PM

#6118 RE: Drugdoctor #6115

cargo_hauler, We need some hard numbers here.

For revenue and share structure, etc. That's the only thing that will make this go.

We can rationalize this thing to death, as to whether it is undervalued, fairly valued, etc. And we can make comparisons to other stocks until hell freezes over. So what? None of that really matters.

In the stock market, as in life, image always trumps reality.

Opinions are not going to cut it. We've had enough glowing opinions. We need to see the facts that are supporting this. It is now obvious that there is dilution, and the company isn't telling us why. Of course, there is an answer for everything here, like "The company doesn't issue many PRs, because... (pick one of several reasons)."

From my viewpoint, the next meaningful signpost is VerSign's financials to be released on 11/1. We should get some verbage about their individual operating units, such as network services including telemarketing. Hopefully, their revenue is expanding and I am looking forward to any guidance about that specific segment of the market.

At this point, I have a lot more faith in Versign than Compliance. IF Verisign says the telemarketing biz is expanding well, then the "trickle down" should help COPI, based on the 82% of revenue we get from Versign. This is NOT rocket science; Verisign is the key.

Still Hopeful, and way long...

VV